Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired...

Area of Science:

• Ophthalmology
• Immunology
• Molecular Biology

Background:

• Inflammation and immune responses are key drivers in age-related macular degeneration (AMD) pathogenesis.
• Elevated C-reactive protein (CRP) levels correlate with increased AMD risk, but its specific role in ocular inflammation remains unclear.
• Understanding CRP's function is crucial for elucidating AMD etiology.

Purpose of the Study:

• To investigate the mechanistic role of CRP in the development of age-related macular degeneration.
• To determine how different forms of CRP influence inflammatory markers in retinal cells.
• To explore the interaction between CRP and complement factor H (FH) in the context of AMD.

Main Methods:

• Cultured human retinal pigment epithelial cells were treated with monomeric CRP (mCRP) and pentameric CRP (pCRP).
• Levels of inflammatory cytokines IL-8 and CCL2 were measured.
• Binding assays were performed to assess the interaction between CRP and complement factor H (FH), including FH variants associated with AMD risk.

Main Results:

• Monomeric CRP (mCRP), but not pentameric CRP (pCRP), significantly upregulated IL-8 and CCL2 expression in retinal pigment epithelial cells.
• Complement factor H (FH) was found to bind mCRP, thereby inhibiting its pro-inflammatory effects.
• FH isolated from AMD patients with the His402 risk polymorphism exhibited reduced binding affinity for mCRP, leading to unrestrained mCRP pro-inflammatory activity.

Conclusions:

• Monomeric CRP (mCRP) acts as a pro-inflammatory agent in the context of age-related macular degeneration (AMD) by stimulating cytokine production in retinal cells.
• Complement factor H (FH) plays a protective role by inhibiting mCRP's pro-inflammatory actions.
• The impaired binding of FH to mCRP due to the His402 risk polymorphism in AMD patients contributes to the disease's inflammatory progression.